BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2022 12:48:14 PM | Browse: 547 | Download: 1722
 |
Received |
|
2022-02-28 23:24 |
|
Peer-Review Started |
|
2022-02-28 23:26 |
|
First Decision by Editorial Office Director |
|
2022-04-17 04:50 |
|
Return for Revision |
|
2022-04-17 04:50 |
|
Revised |
|
2022-04-21 14:14 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-07-29 02:52 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-08-01 04:09 |
|
Articles in Press |
|
2022-08-01 04:09 |
|
Edit the Manuscript by Language Editor |
|
2022-07-25 10:50 |
|
Typeset the Manuscript |
|
2022-08-31 07:56 |
|
Publish the Manuscript Online |
|
2022-09-09 12:48 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Clinical implications of interleukins-31, 32, and 33 in gastric cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qing-Hua Liu, Ji-Wei Zhang, Lei Xia, Steven G Wise, Brett David Hambly, Kun Tao and Shi-San Bao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81502030 |
|
| Corresponding Author |
Shi-San Bao, MD, PhD, Academic Fellow, Department of Pathology, Tongren Hospital, No. 1111 Xianxia Road, Changning Distric, Shanghai 200336, China. bob.bao@sydney.edu.au |
| Key Words |
Diagnosis and therapy; Gastric cancer; Immune cell interactions; Interleukin-31; Interleukin 32; Interleukin-33 |
| Core Tip |
Gastric cancer (GC) is one of the most common malignancies in China with a high morbidity and mortality. This study aimed to determine whether interleukin (IL)-31, IL-32, and IL-33 can be used as biomarkers for the detection of GC, via evaluating the correlations between their expression and clinicopathological parameters of GC patients. IL-31, IL-32, and IL-33 expression in GC was correlated with the severity of clinicopathological parameters. Circulating IL-33 was significantly low in GC patients. Our findings may provide new insights into the roles of IL-31, IL-32, and IL-33 in the carcinogenesis of GC. |
| Publish Date |
2022-09-09 12:48 |
| Citation |
Liu QH, Zhang JW, Xia L, Wise SG, Hambly BD, Tao K, Bao SS. Clinical implications of interleukins-31, 32, and 33 in gastric cancer. World J Gastrointest Oncol 2022; 14(9): 1808-1822 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i9/1808.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i9.1808 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
